(Q38230605)

31 August 2017

1 reference

title

Muromonab CD3. A review of its pharmacology and therapeutic potential (English)

1 reference

31 August 2017

1 reference

2

Brogden RN

1 reference

31 August 2017

Todd PA

1

1 reference

31 August 2017

publication date

1 June 1989

1 reference

31 August 2017

1 reference

31 August 2017

volume

37

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

871-899

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198937060-00004

31 August 2017

exact match

0 references

cites work

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

12 December 2020

Cadaveric renal transplantation in the cyclosporine and OKT3 eras

1 reference

12 December 2020

Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection

1 reference

12 December 2020

Allogeneic bone marrow transplantation: the monitoring of granulocyte macrophage colonies following the collection of bone marrow mononuclear cells and after the subsequent in-vitro cytolysis of OKT3 positive lymphocytes

1 reference

12 December 2020

Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection

1 reference

12 December 2020

Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation

1 reference

12 December 2020

OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

1 reference

12 December 2020

The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine

1 reference

12 December 2020

Portal vein gas and sepsis after administration of OKT3

1 reference

12 December 2020

Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial

1 reference

12 December 2020

Graft-versus-host disease prophylaxis with anti-T-cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone-marrow transplantation

1 reference

12 December 2020

ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid Therapy

1 reference

12 December 2020

Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody

1 reference

12 December 2020

Histologic response to OKT3 therapy for hepatic allograft rejection

1 reference

12 December 2020

A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection.

1 reference

12 December 2020

Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation

1 reference

12 December 2020

The human T-cell receptor. Structure and function

1 reference

12 December 2020

Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes

1 reference

12 December 2020

Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies

1 reference

12 December 2020

Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation

1 reference

12 December 2020

The human immune response to the OKT3 monoclonal antibody is oligoclonal

1 reference

12 December 2020

Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens

1 reference

12 December 2020

Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex

1 reference

12 December 2020

Use of antithymocyte globulin for reversal of acute allograft rejection

1 reference

12 December 2020

Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3

1 reference

12 December 2020

Nosocomial aseptic meningitis associated with administration of OKT3

1 reference

12 December 2020

Effect of antilyphocyte-globulin potency on survival of cadaver renal transplants. Prospective randomised double-blind trial

1 reference

12 December 2020

Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine

1 reference

12 December 2020

Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors

1 reference

12 December 2020

Rescue of severe steroid-resistant rejection with OKT3.PAN.

1 reference

12 December 2020

Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation

1 reference

12 December 2020

OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejection.

1 reference

12 December 2020

OKT3 rescue therapy in pancreas-allograft rejection

1 reference

12 December 2020

OKT3 salvage therapy in a quadruple immunosuppressive protocol in cadaveric renal transplantation.

1 reference

12 December 2020

Complications and monitoring of OKT3 therapy

1 reference

12 December 2020

Reversal of transplant rejection by monoclonal antiblast antibody

1 reference

12 December 2020

Reexposure to OKT3 in renal allograft recipients

1 reference

12 December 2020

T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex

1 reference

12 December 2020

Impact of Orthoclone OKT3 on liver transplantation

1 reference

12 December 2020

Infections in patients receiving OKT3 monoclonal antibody for cardiac rejection: results of a small clinical trial.

1 reference

12 December 2020

Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation

1 reference

12 December 2020

Anti-thymocyte globulin effective in the treatment of aplastic anemia does not stimulate granulocyte precursor cells

1 reference

12 December 2020

OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.

1 reference

12 December 2020

Monoclonal anti-T12 antibody as therapy for renal allograft rejection

1 reference

12 December 2020

Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report

1 reference

12 December 2020

Monoclonal antilymphocyte antibody (OKT3) treatment of acute renal allograft rejection

1 reference

12 December 2020

OKT3 and pulmonary capillary permeability.

1 reference

12 December 2020

Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants.

1 reference

12 December 2020

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection

1 reference

12 December 2020

OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A

1 reference

12 December 2020

Rejection prophylaxis with murine monoclonal CD-3 antibody (OKT3): considerations for early hospital discharge

1 reference

12 December 2020

Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?

1 reference

12 December 2020

Human gamma interferon production by leukocytes induced with monoclonal antibodies recognizing T cells

1 reference

12 December 2020

[Preventive treatment of rejection by the prolonged administration of OKT3: decrease of the immune response of the host]

1 reference

12 December 2020

Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody

1 reference

12 December 2020

Surface structures involved in target recognition by human cytotoxic T lymphocytes

1 reference

12 December 2020

Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin

1 reference

12 December 2020

Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

1 reference

12 December 2020

Influence of low-dose cyclosporine on the outcome of treatment with OKT3 for acute renal allograft rejection

1 reference

12 December 2020

OKT3 and cerebral oedema

1 reference

12 December 2020

Cerebrospinal fluid inflammation during OKT3 therapy.

1 reference

12 December 2020

Lymphocyte function in patients treated with monoclonal anti-T3 antibody for acute cadaveric renal allograft rejection

1 reference

12 December 2020

In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia

1 reference

12 December 2020

Diagnostic and therapeutic applications of monoclonal antibodies to human T-cell subsets in renal transplant recipients

1 reference

12 December 2020

OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3

1 reference

12 December 2020

Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody.

1 reference

12 December 2020

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

12 December 2020

Successful retreatment of allograft rejection with OKT3

1 reference

12 December 2020

OKT3 rescue in refractory renal rejection.

1 reference

12 December 2020

Treatment of acute renal allograft rejection with OKT3 monoclonal antibody

1 reference

12 December 2020

Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection

1 reference

12 December 2020

OKT3 monoclonal antibody inhibits cytotoxic T lymphocyte mediated cell lysis

1 reference

12 December 2020

A U.S. clinical study of Orthoclone OKT3 in renal transplantation

1 reference

12 December 2020

Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine

1 reference

12 December 2020

OKT3 delays rejection crises after heart transplantation.

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with monoclonal antibody OKT3. Clinical results and effect on circulating T lymphocytes

1 reference

12 December 2020

Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease. A pilot study in ten patients

1 reference

12 December 2020

Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy

1 reference

12 December 2020

Monoclonal antibodies for the diagnosis and treatment of transplant rejection

1 reference

12 December 2020

Clinical development of Orthoclone OKT3.

1 reference

12 December 2020

A quantitative study of the binding of ALS to various cell types

1 reference

12 December 2020

The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.

1 reference

12 December 2020

Monitoring immunosuppression following renal transplantation

1 reference

12 December 2020

Differentiation human leukocyte antigens: a proposed nomenclature

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Effect of OKT3 on survival and rate of retransplantation

1 reference

12 December 2020

Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation

1 reference

12 December 2020

Unusually restricted anti-isotype human immune response to OKT3 monoclonal antibody

1 reference

12 December 2020

Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens

1 reference

12 December 2020

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

1 reference

12 December 2020

One-month prophylactic use of OKT3 in cadaver kidney transplant recipients

1 reference

12 December 2020

A monoclonal antibody blocking human T cell function

1 reference

12 December 2020

Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments

1 reference

12 December 2020

Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.

1 reference

12 December 2020

Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection

1 reference

12 December 2020

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

12 December 2020

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

12 December 2020

A monoclonal anti-pan-T-cell antibody. In vitro and in vivo studies

1 reference

12 December 2020

Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen

1 reference

12 December 2020

OKT3 induces suppressor cells for mixed lymphocyte and PHA mitogenic responses in human peripheral lymphocytes

1 reference

12 December 2020

A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.

1 reference

12 December 2020

10.2165/00003495-198937060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1027805681

0 references

1 reference